Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2000
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036169A1 Nucleic acid mediated rna tagging and rna revision
09/20/2000EP1036164A1 Chemokine alpha-5
09/20/2000EP1036095A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
09/20/2000EP1036092A2 Hydrophobically-modified protein compositions and methods
09/20/2000EP1036086A1 Caspase-14 polypeptides
09/20/2000EP1036078A1 Thienopyrimidines
09/20/2000EP1036073A1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
09/20/2000EP1036072A1 Thrombin receptor antagonists
09/20/2000EP1036069A1 Benzenesulfonamide compounds
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
09/20/2000EP1036064A1 Selective beta 3-adrenergic agonists
09/20/2000EP1036063A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1036061A1 New compounds
09/20/2000EP1035851A2 Method for combating obesity
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035845A1 Modulators of cysteine protease
09/20/2000EP1035843A2 I h?-MODULATORS
09/20/2000EP1035842A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
09/20/2000EP1035835A1 Long acting injectable formulations containing hydrogenated castor oil
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP1035780A1 Method for purifying heat shock peptides complexes
09/20/2000EP0934072A4 Manufacturing process for the production of purified transferrin
09/20/2000EP0792291B1 Protein affecting katp channels
09/20/2000EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000EP0672057B1 Analogs of pth
09/20/2000EP0586549B1 Selecting ligand agonists and antagonists
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267302A Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
09/20/2000CN1267299A Aminooxyamide tricyclic inhibitors of farnesylprotein transferase
09/20/2000CN1267298A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase
09/20/2000CN1267297A Benzo (5,6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1267294A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. for inhibition of farnesyl-protein transferase
09/20/2000CN1267293A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. useful for inhibition of farnesyl-protein transferase
09/20/2000CN1267292A Phenyl-substd. tricyclic inhibitors of farnesyl-protein transferase
09/20/2000CN1267289A Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
09/20/2000CN1267286A 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
09/20/2000CN1267225A Method for treatment of patients afflicted with multiple sclerosis using consensus interferon
09/20/2000CN1267221A Method of enhancing bioavailability of fexofenadine and its derivs.
09/20/2000CN1266712A Oral liquid for preventing altitude disease and its preparing process
09/20/2000CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same
09/20/2000CN1056610C Piperidine or piperazine derivs, pharmaceutical compositions contg. them and their use
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056605C Compounds as selective human NK 3-receptor antagonists and their use
09/20/2000CN1056602C Esters and amides as PLAZ inhibitors
09/20/2000CN1056526C Extract for giving up drug-taking
09/20/2000CN1056520C Anti-senility hypolpemic Chinese medicine liquor
09/20/2000CN1056519C Medicine for prevention and treatment of iodine-deficient disease and preparation method thereof
09/20/2000CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use
09/19/2000US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
09/19/2000US6121461 Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
09/19/2000US6121449 Testosterone 5 alpha-reductase inhibitory activity; useful in therapy in the treatment of hyperandrogenic conditions
09/19/2000US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics
09/19/2000US6121325 Naphthyl compounds promote release of growth hormone
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing
09/19/2000US6121312 Cyclic ether vitamin D3 compounds and uses thereof
09/19/2000US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals
09/19/2000US6121297 Cyanoguanidines as cell proliferation inhibitors
09/19/2000US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin
09/19/2000US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction
09/19/2000US6121293 Benzothiophene compounds, compositions, and methods
09/19/2000US6121290 Use of GABA uptake inhibitors as anti-tussive agents
09/19/2000US6121283 N-substituted-6-(2-(4-trifluoromethylphenyl)phenylcarbonyl-amino) -1,2,3,4-tetrahydroisoquinolines; treating disorders including obesity, hyperlipidemia, and diabetes; microsomal triglyceride transfer protein (mtp); apolipoprotein b (apo-b)
09/19/2000US6121280 Azabicyclic rotomase inhibitors
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121266 Pyridazines as interleukin-1β converting enzyme inhibitors
09/19/2000US6121263 Administering synergistic amount of a 1,2,4-benzotriazine-n-oxide derivative prior to administering taxol
09/19/2000US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist
09/19/2000US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
09/19/2000US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
09/19/2000US6121252 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitors to treat glutamate abnormalities and prostate diseases
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6121240 Urokinase receptor ligands
09/19/2000US6121238 Peptides and compounds that bind to a receptor
09/19/2000US6121047 Antisense modulation of SHP-1 expression
09/19/2000US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache
09/19/2000US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/19/2000US6120765 Purified peptide
09/19/2000US6120761 Mixture containing histidine stabilizer
09/19/2000US6119687 Partial liquid breathing of fluorocarbons
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/19/2000CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use
09/19/2000CA2029420C Pharmaceutical compositions and methods for inhibition of maillard's reaction
09/14/2000WO2000053800A1 METHOD TO SEARCH FOR MALE ANTIFERTILITY DRUGS BASED ON PHGPx ACTIVITY DETERMINATION
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053604A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000WO2000053600A1 Novel piperidine derivatives
1 ... 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 ... 1564